Sökresultat - Portal för medicinska datamodeller (MDM-portal)

Filtrera sökresultat
Välj datamodell

Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

427 Sökresultat.

Kerndatensatz Herzinsuffizienz DZHI (Core data set heart failure CHFC) - Untersuchung Herzinsuffizienz (Examination heart failure)

- 2020-03-24 - 1 Formulär, 5 Item-grupper, 90 Dataelement, 2 Språk

Item-grupper: Logistics , Physical examination, ECG, 6MWT, Echocardiography

Core data set on heart failure, developed by the Comprehensive Heart Failure Center (CHFC). The CHFC researches and treats the complex disease heart failure and its comorbidities in a comprehensive approach. This form contains information about the examination of an heart failure Kerndatensatz zu Herzinsuffizienz, entwickelt vom Deutschen Zentrum für Herzinsuffizienz (DZHI). Das DZHI erforscht und therapiert in einem ganzheitlichen Ansatz die Systemerkrankung Herzinsuffizienz samt ihrer Begleit- und Folgeerkrankungen. Dieses Formular enthält Informationen über die Untersuchung einer Herzinsuffizienz.

Telemedical Interventional Management in Heart Failure II (TIM-HF II) NCT01878630 - Baseline Visit

- 2017-11-14 - 1 Formulär, 10 Item-grupper, 71 Dataelement, 2 Språk

Item-grupper: Physical Examination / Medical History taking, Signs and Symptoms of heart failure, Cardiovascular Diseases, Comorbidities, Current medication, Cardiovascular interventions, Implantation of a cardiac device, Hematology, ECG, Baseline visit

Short title: TIM-HF II Permission to publish granted by: Prof. Dr. Friedrich Köhler, FESC Charité - Universitätsmedizin Berlin Further study details on: https://www.clinicaltrials.gov/ct2/show/NCT01878630 Baseline Visit (BV-Form)

Eligibility Heart Failure NCT00083772

- 2021-09-27 - 1 Formulär, 3 Item-grupper, 16 Dataelement, 1 Språk

Item-grupper: Criteria, Inclusion Criteria, Exclusion Criteria

Use of Nesiritide in the Management of Acute Diastolic Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00083772

Eligibility Heart Failure, Congestive NCT00439842

- 2021-09-27 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk

Item-grupper: Inclusion Criteria, Exclusion Criteria

Self-Management and Care of Heart Failure With Group Clinics (SMAC-HF); ODM derived from: https://clinicaltrials.gov/show/NCT00439842

Eligibility Heart Failure, Congestive NCT00399594

- 2021-09-27 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk

Item-grupper: Inclusion Criteria, Exclusion Criteria

Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.; ODM derived from: https://clinicaltrials.gov/show/NCT00399594

Eligibility Heart Failure NCT00990665

- 2021-09-27 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk

Item-grupper: Inclusion Criteria, Exclusion Criteria

Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study; ODM derived from: https://clinicaltrials.gov/show/NCT00990665

Eligibility Beta Blocker Intolerance; NCT02173028

- 2021-09-27 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk

Item-grupper: Inclusion Criteria, Exclusion Criteria

RESynchronizaTiOn theRapy and bEta-blocker Titration; ODM derived from: https://clinicaltrials.gov/show/NCT02173028

Endpoint Hospitalisation for heart failure GSK study Chronic Coronary Heart Disease NCT00799903

- 2021-09-20 - 1 Formulär, 3 Item-grupper, 43 Dataelement, 1 Språk

Item-grupper: Investigator section, CEC Section, CEC Status

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Endpoint Hospitalisation for heart failure - Repeating form (Scheduled visits)

Eligibility Heart Failure NCT00918294

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 10 Dataelement, 1 Språk

Item-grupper: Inclusion Criteria, Exclusion Criteria

QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization; ODM derived from: https://clinicaltrials.gov/show/NCT00918294

Eligibility Congestive Heart Failure NCT00944125

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk

Item-grupper: Inclusion Criteria, Exclusion Criteria

Dual Site Left Ventricular (LV) Pacing; ODM derived from: https://clinicaltrials.gov/show/NCT00944125

Eligibility Heart Failure NCT00795873

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk

Item-grupper: Inclusion Criteria, Exclusion Criteria

OVATIO CRT and SITUS OTW LV Lead Post Approval Study; ODM derived from: https://clinicaltrials.gov/show/NCT00795873

Eligibility Heart Failure at NYHA Stage III or IV NCT01126944

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 20 Dataelement, 1 Språk

Item-grupper: Inclusion Criteria, Exclusion Criteria

LVAD in Non Cardiac Transplant Candidates and Non Responders to Resynchronization; ODM derived from: https://clinicaltrials.gov/show/NCT01126944

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.